Clinical Trials Directory

Trials / Unknown

UnknownNCT06131125

Plyometric vs Explosive Strength Training on Agility, Power, and Balance in Basketball Players

Comparative Effects of Plyometric and Explosive Strength Training on Agility, Power, and Dynamic Balance in Basketball Players

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
17 Years – 25 Years
Healthy volunteers
Accepted

Summary

The study is randomized and single-blinded. Ethical approval is taken from Ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in groups A \& B through the sealed envelope method by Non-probability Convenient random sampling technique. Subjects in group A will receive plyometric training. Group B will receive explosive strength training.

Detailed description

The objective of the study is to determine the effects of plyometric training versus explosive strength training on agility, power, and dynamic balance in basketball players. The study is randomized and single-blinded. Ethical approval is taken from the Ethical Committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in groups A \& B through the sealed envelope method by Non-probability Convenient random sampling technique. Subjects in group A will receive plyometric training. Group B will receive explosive strength training. The outcome measures will be assessed by agility T-test, vertical jump test, and star excursion balance test (SEBT). The data will be analyzed by SPSS, version 25. Statistical significance is p=0.05.

Conditions

Interventions

TypeNameDescription
OTHERPlyometric training exercisesThis includes plyometric training exercises thrice a week for 6 weeks
OTHERExplosive strength training exercisesthis includes explosive strength training exercises thrice a week for 6 weeks

Timeline

Start date
2023-10-20
Primary completion
2024-02-20
Completion
2024-02-20
First posted
2023-11-14
Last updated
2023-11-14

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06131125. Inclusion in this directory is not an endorsement.